Sangamo Therapeutics, Inc.Sangamo Therapeutics, Inc.Sangamo Therapeutics, Inc.

Sangamo Therapeutics, Inc.

No trades
See on Supercharts

Price target

6.330.000.00%
The 6 analysts offering 1 year price forecasts for SGMO have a max estimate of — and a min estimate of —.

Analyst rating

Based on 8 analysts giving stock ratings to SGMO in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


SGMO EPS for the last quarter is 0.04 USD despite the estimation of −0.02 USD. In the next quarter EPS is expected to reach −0.09 USD. Track more of Sangamo Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Sangamo Therapeutics, Inc. revenue is expected to reach ‪8.84 M‬ USD. Check out Sangamo Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, SGMO price target is 6.33 USD with a max estimate of 10.00 USD and a min estimate of 2.00 USD. Check if this forecast comes true in a year, meanwhile watch Sangamo Therapeutics, Inc. stock price chart and keep track of the current situation with SGMO news and stock market news.
We've gathered opinions of 8 analysts rating SGMO stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.